With world-class expertise in ctDNA analysis, Inivata is committed to partnering with pharmaceutical and biotech companies to accelerate clinical research to aid development of targeted therapies and immuno-oncology drugs and improve patient outcomes.
Inivata can provide comprehensive ctDNA testing services to our pharma/biotech partners for:
– Molecular stratification
– Monitoring treatment response
– Detection of disease relapse
– Identification of resistance mutations
– Detection of minimal residual disease
– Earlier diagnosis